RG002C0106

· Rigerna Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RG002C0106, covering 2026-03-03 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study to Evaluate the Safety/Tolerability, PK/PD of RG002C0106 Injection in Healthy Adults [Phase 1]